FDA Grants Orphan Drug Designation for BE-101, a Novel Engineered B Cell Medicine, for the Treatment of Hemophilia B June 4, 2024
TScan Receives FDA’s Regenerative Medicine Advanced Therapy Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies May 29, 2024
Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute May 28, 2024
Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases May 20, 2024
